Dialogues

Aug 1, 2025, 07:45

Empowering Oncologists: Is it time to redesign the future of clinical trials?

In this episode of Empowering Oncologists, Dr. Jasmine Kamboj welcomes Dr. Sandip Patel for an in-depth conversation on the future of cancer research, clinical trial access, and the evolving role of young oncologists in shaping innovation.

Dr. Patel shares his journey from Texas to UC San Diego, his passion for immunotherapy and early-phase trials, and what it means to lead with purpose in a field where science meets humanity. Together, they explore how we can rethink clinical trial design to be more inclusive, efficient, and patient-centered.

Key Highlights:

The hidden burden of time toxicity in cancer trials
Rethinking trial design: Are we designing for patients or data?
The power of cooperative groups in training the next generation
Real-world strategies: AI tools, remote monitoring, and hub-and-spoke models
Advice for trainees: Find your niche—and don’t expect a linear path

00:00 Introduction
02:28 Why UC San Diego?
02:34 Role in Solid Tumor & Experimental Therapeutics
04:13 Developing phase I trials for rare tumors
05:18 Making “cold tumors hot” – immunotherapy focus
06:17 NRG Oncology and cross-specialty collaboration
07:42 Cooperative group trials vs. pharma trials
09:03 Trials reaching community settings
10:20 Trial complexity and regulatory burden
11:52 Time toxicity in clinical trials
12:18 Role of AI and remote monitoring
14:06 Site feasibility and paperwork
15:04 Reducing burden on staff and patients
16:21 Lack of access in 70% of U.S. counties
16:32 Inclusion/exclusion criteria critique
20:03 ASCO’s impact on education and diversity
22:00 Advice to younger self
25:32 Favorite non-thoracic study
28:15 Would choose oncology again